Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,658,000 | 8,994,000 | 5,917,000 | 4,528,000 | 11,112,000 |
| Marketable Securities | 1,905,000 | 1,876,000 | 376,000 | 445,000 | 334,000 |
| Receivables | 8,456,000 | 8,299,000 | 7,952,000 | 8,795,000 | 8,555,000 |
| Inventories | 7,131,000 | 7,136,000 | 6,904,000 | 6,398,000 | 5,982,000 |
| Other current assets | 2,523,000 | 2,668,000 | 2,733,000 | 2,932,000 | 3,521,000 |
| TOTAL | $29,673,000 | $28,973,000 | $23,882,000 | $23,098,000 | $29,504,000 |
| Non-Current Assets | |||||
| PPE Net | 12,263,000 | 11,711,000 | 11,955,000 | 11,933,000 | 12,069,000 |
| Investments And Advances | 12,533,000 | 11,603,000 | 11,050,000 | 8,303,000 | 8,644,000 |
| Intangibles | 66,808,000 | 66,415,000 | 65,769,000 | 66,388,000 | 55,311,000 |
| Other Non-Current Assets | 6,501,000 | 10,976,000 | 11,107,000 | 13,375,000 | 12,842,000 |
| TOTAL | $98,105,000 | $100,705,000 | $99,881,000 | $99,999,000 | $88,866,000 |
| Total Assets | $127,778,000 | $129,678,000 | $123,763,000 | $123,097,000 | $118,370,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,785,000 | 9,727,000 | 8,875,000 | 10,956,000 | 7,031,000 |
| Accounts payable and accrued liabilities | 5,403,000 | 4,705,000 | 4,820,000 | 4,828,000 | 5,424,000 |
| Other current liabilities | 15,127,000 | 14,425,000 | 12,858,000 | 12,956,000 | 13,369,000 |
| TOTAL | $33,059,000 | $31,838,000 | $29,382,000 | $31,294,000 | $28,264,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 26,259,000 | 26,497,000 | 23,955,000 | 23,800,000 | 20,353,000 |
| Other Non-Current Liabilities | 8,648,000 | 9,365,000 | 9,042,000 | 9,505,000 | 8,331,000 |
| TOTAL | $38,053,000 | $43,286,000 | $40,496,000 | $40,826,000 | $34,555,000 |
| Total Liabilities | $71,112,000 | $75,124,000 | $69,878,000 | $72,120,000 | $62,819,000 |
| Shareholders' Equity | |||||
| Common Shares | 913,000 | 913,000 | 913,000 | 936,000 | 936,000 |
| Retained earnings | 55,738,000 | 53,615,000 | 52,936,000 | 50,035,000 | 54,618,000 |
| Other shareholders' equity | 68,000 | 70,000 | 73,000 | 74,000 | 77,000 |
| TOTAL | $56,666,000 | $54,554,000 | $53,885,000 | $50,977,000 | $55,551,000 |
| Total Liabilities And Equity | $127,778,000 | $129,678,000 | $123,763,000 | $123,097,000 | $118,370,000 |